Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Morris

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Nature Communications|October 3, 2025
A safe, T cell-inducing heterologous vaccine against elephant endotheliotropic herpesvirus in a proof-of-concept studyTanja Maehr, Javier Lopez, Gabby Drake, et al.
NPJ Vaccines|February 15, 2023
Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigsEleni Vatzia, Katherine Feest, Adam McNee, et al.
Iscience|September 28, 2023
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surfaceTao Ni, Luiza Mendonça, Yanan Zhu, et al.
International Wound Journal|January 4, 2007
Reimbursement of dressings: a WUWHS statementLuc Téot, George Cherry, Catherine Denis, et al.
NPJ Vaccines|June 26, 2024
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccineCameron Bissett, Sandra Belij-Rammerstorfer, Marta Ulaszewska, et al.
The Journal of Experimental Medicine|October 30, 2025
Heterologous mucosal vaccine boosting enhances mucosal and systemic immunity by distinct mechanismsCameron Bissett, Lyn Yong, Alexandra J Spencer, et al.
Frontiers in Immunology|November 22, 2021
Respiratory and Intramuscular Immunization With ChAdOx2-NPM1-NA Induces Distinct Immune Responses in H1N1pdm09 Pre-Exposed PigsEleni Vatzia, Elizabeth R Allen, Tanuja Manjegowda, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
ACS Central Science|May 31, 2021
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 VaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
Ebiomedicine|March 1, 2022
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studiesAlexandra J Spencer, Susan Morris, Marta Ulaszewska, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Nature Communications|October 3, 2025
A safe, T cell-inducing heterologous vaccine against elephant endotheliotropic herpesvirus in a proof-of-concept studyTanja Maehr, Javier Lopez, Gabby Drake, et al.
NPJ Vaccines|February 15, 2023
Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigsEleni Vatzia, Katherine Feest, Adam McNee, et al.
Iscience|September 28, 2023
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surfaceTao Ni, Luiza Mendonça, Yanan Zhu, et al.
International Wound Journal|January 4, 2007
Reimbursement of dressings: a WUWHS statementLuc Téot, George Cherry, Catherine Denis, et al.
NPJ Vaccines|June 26, 2024
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccineCameron Bissett, Sandra Belij-Rammerstorfer, Marta Ulaszewska, et al.
The Journal of Experimental Medicine|October 30, 2025
Heterologous mucosal vaccine boosting enhances mucosal and systemic immunity by distinct mechanismsCameron Bissett, Lyn Yong, Alexandra J Spencer, et al.
Frontiers in Immunology|November 22, 2021
Respiratory and Intramuscular Immunization With ChAdOx2-NPM1-NA Induces Distinct Immune Responses in H1N1pdm09 Pre-Exposed PigsEleni Vatzia, Elizabeth R Allen, Tanuja Manjegowda, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
ACS Central Science|May 31, 2021
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 VaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
Ebiomedicine|March 1, 2022
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studiesAlexandra J Spencer, Susan Morris, Marta Ulaszewska, et al.
Pageof 11